PharmVar GeneFocus: CYP2C19

The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. Th...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2021-02, Vol.109 (2), p.352-366
Main Authors: Botton, Mariana R., Whirl‐Carrillo, Michelle, Del Tredici, Andria L., Sangkuhl, Katrin, Cavallari, Larisa H., Agúndez, José A. G., Duconge, Jorge, Lee, Ming Ta Michael, Woodahl, Erica L., Claudio‐Campos, Karla, Daly, Ann K., Klein, Teri E., Pratt, Victoria M., Scott, Stuart A., Gaedigk, Andrea
Format: Article
Language:English
Subjects:
Alleles
Cytochrome P-450 CYP2C19 - genetics
Genetic Variation - genetics
Genotype
Haplotypes - genetics
Humans
Knowledge Bases
Pharmacogenetics - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. This GeneFocus provides a comprehensive overview and summary of CYP2C19 and describes how haplotype information catalogued by PharmVar is utilized by the Pharmacogenomics Knowledgebase and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
ISSN:0009-9236
1532-6535
1532-6535
DOI:10.1002/cpt.1973